(Q39849716)

English

New targets of PS-341: BAFF and APRIL.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

New targets of PS-341: BAFF and APRIL. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Wuping Li

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Juan Li

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Chang Su

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Wai Yi Zou

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Shaokai Luo

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

439-445

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

https://scigraph.springernature.com/pub.10.1007/s12032-009-9230-z

0 references

In vitro and in vivo activation induces BAFF and APRIL expression in B cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9230-Z

21 January 2018

Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bortezomib (PS-341) in patients with human herpesvirus 8-associated primary effusion lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global cancer statistics, 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two related ligands of the TNF family, BAFF and APRIL, in rabbit: molecular cloning, 3D modeling, and tissue distribution

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble Fms-like tyrosine kinase-1 expression inhibits the growth of multiple myeloma in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A role for B cell-activating factor of the TNF family in chemically induced autoimmunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteasome inhibition in cancer: development of PS-341.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone

1 reference

https://pubmed.ncbi.nlm.nih.gov/19452288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-009-9230-Z

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39849716&oldid=2091474511"